Innovacell Inc. (504A) Press Release
(Delayed) Quarterly Update_Q2 FY2026
Earlier from Innovacell
- Patient Enrollment Status of the ICEF15 Multi-Regional Phase III Clinical Trial (Fidelia) and Completion of Patient Recruitment in Japan and Europe
- Announcement Regarding the Execution of a Product Commercialization Agreement with EVERSANA Life Science Services, LLC for the U.S. Market
- Announcement Regarding Completion of FDA IND Review and Approval to Include U.S. Sites and Patients in the ICEF15 Multi-Regional Phase III Trial